N
NVCT icon

Nuveen’s Nuvectis Pharma NVCT Stock Holding History

Nuveen’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Hold
16,749
– – ﹤0.01% 3159
2025
Q4 		$126K Hold
16,749
– – ﹤0.01% 3197
2025
Q3 		$101K Hold
16,749
– – ﹤0.01% 3222
2025
Q2 		$125K Buy
+16,749
New +$152K ﹤0.01% 3236
2024
Q2 		– Sell
-11,883
Closed -$97.4K – 3390
2024
Q1 		$97.4K Hold
11,883
– – ﹤0.01% 3251
2023
Q4 		$99.1K Buy
11,883
+1,214
+11% +$10.8K ﹤0.01% 3287
2023
Q3 		$138K Hold
10,669
– – ﹤0.01% 3090
2023
Q2 		$170K Buy
+10,669
New +$170K ﹤0.01% 3115

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen's NVCT Position: Q1 2026 in Review

Nuveen held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 16,749 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3159.

Nuveen first reported a position in NVCT in Q2 2023 and has held it in 8 quarters since. The position peaked at $170K in Q2 2023. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Nuveen held 16,749 shares of Nuvectis Pharma worth $129K as of Q1 2026.
  • Nuveen left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3159 holding.
  • Nuveen first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 8 quarters since.
  • Nuveen's Nuvectis Pharma position peaked at $170K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.